Détention brevets de la classe A61K 38/18

Brevets de cette classe: 5820

Historique des publications depuis 10 ans

514
505
509
519
454
425
478
330
325
102
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Propriétaires principaux

Proprétaire
Total
Cette classe
The Regents of the University of California
19705
116
Regeneron Pharmaceuticals, Inc.
4150
95
Acceleron Pharma Inc.
359
80
Warsaw Orthopedic, Inc.
3048
64
Amgen Inc.
3988
61
Novartis AG
11011
58
The Board of Trustees of the Leland Stanford Junior University
6302
57
NGM Biopharmaceuticals, Inc.
176
53
President and Fellows of Harvard College
5908
52
University of Pittsburgh - Of the Commonwealth System of Higher Education
3097
50
Modernatx, Inc.
1252
43
Translate bio, Inc.
407
43
New York University
1717
41
The General Hospital Corporation
4679
38
The Trustees of the University of Pennsylvania
4280
35
The Salk Institute for Biological Studies
446
33
Zensun (Shanghai) Science & Technology, Co., Ltd.
55
31
Dompé Farmaceutici S.p.A.
260
28
The Brigham and Women's Hospital, Inc.
2148
27
Merck Patent GmbH
5831
26
Autres propriétaires 4789